ABBV-706

DB18710InvestigationalProtein Based Therapies

ABBV-706 is an antibody-drug conjugate that is anti-SEZ6.

Mechanism: Pharmacologically active on Seizure protein 6 homolog
Curator reviewed
Also known as: ABBV 706 · ABBV706

Resolves to

Targets

What you can answer from here — as of August 10, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with ABBV-706, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.